The companies that take GenAI from experimental to enterprise-ready will gain a competitive edge in the 2024 market. Yet many business leaders hesitate to adopt this explosive technology because of risks like hallucination and unexplainability.
Ā
A report fromĀ Enterprise Strategy Group examines todayās landscape, including the opportunities for businesses that invest in GenAI. The analyst covers:
Ā
Ā
Donāt wait for your competition to outpace you with GenAI. See what the analyst names āthe strongest grounding option.ā
*Required fields
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |